Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.76−0.23 (-7.69%)
Close on Nov 17, 2026Market cap $113.34MP/E –Yield –
Scienture price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Scienture's price to sales ratio was 402.1× on Jan 30, 2026, against 27.5× a year earlier. Over the last 5 years it ranged from 6.8× to 451.4×, with a median of 61.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 402.1× | −49.3 |
| 2025 | Dec 31, 2025 | 451.4× | +352.5 |
| 2024 | Apr 30, 2024 | 98.9× | +68.6 |
| 2023 | Dec 29, 2023 | 30.3× | +22.6 |
| 2022 | Dec 30, 2022 | 7.7× | −43.0 |
| 2021 | Dec 31, 2021 | 50.7× | −12.7 |
| 2020 | Dec 31, 2020 | 63.4× | −87.6 |
| 2019 | Dec 31, 2019 | 151.0× | +79.0 |
| 2018 | Dec 31, 2018 | 72.1× | −55.3 |
| 2017 | Dec 29, 2017 | 127.4× | +18.2 |
| 2016 | Dec 30, 2016 | 109.2× | −100.9 |
| 2015 | Dec 31, 2015 | 210.1× | – |
See a number that looks wrong?